CYNTHIA DAVIS: Open Payments
NPI 1164918546 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 9 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $362 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Daiichi Sankyo Inc. | 1 | $30 |
| TAIHO ONCOLOGY, INC. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $20 |
| Iovance Biotherapeutics, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| JAZZ PHARMACEUTICALS INC. | 1 | $16 |
Products named: Enhertu, LONSURF, KISQALI, SCEMBLIX, RYBREVANT, Amtagvi, EMRELIS, ZEPZELCA.
Industry payments across NY — which companies pay providers there.
